Detalles de la búsqueda
1.
GWAS and meta-analysis identifies multiple new genetic mechanisms underlying severe Covid-19.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22271833
2.
Systematic comparison of ranking aggregation methods for gene lists in experimental results
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-475491
3.
Systematic review and meta-analysis identifies potential host therapeutic targets in COVID-19.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20182238
4.
Pandemic, epidemic, endemic: B cell repertoire analysis reveals unique anti-viral responses to SARS-CoV-2, Ebola and Respiratory Syncytial Virus
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-456951
5.
Secreted SARS-CoV-2 ORF8 modulates the cytokine expression profile of human macrophages
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-456266
6.
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20248279
7.
Evaluation of the effectiveness of remdesivir in treating severe COVID-19 using data from the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, national cohort study.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21259072
8.
Recovery from Covid-19 critical illness: a secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21258879
9.
Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20137273
10.
Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth properties of B.1.1.7 and B.1.351 lineage viruses in context.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-437704
11.
Identification and quantification of SARS-CoV-2 leader subgenomic mRNA gene junctions in nasopharyngeal samples shows phasic transcription in animal models of COVID-19 and aberrant pattens in humans
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-433753
12.
A common TMPRSS2 variant protects against severe COVID-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21252931
13.
Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the WHO ISARIC CCP-UK prospective cohort study.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22278576
14.
Apixaban following discharge in hospitalised adults with COVID-19: Preliminary results from a multicentre, open-label, randomised controlled platform clinical trial.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22283175
15.
Elevated antiviral, myeloid and endothelial inflammatory markers in severe COVID-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20209411
16.
Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: Findings from a Mendelian randomisation study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22277638
17.
Robust, reproducible clinical patterns in hospitalised patients with COVID-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20168088
18.
Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20076042
19.
SARS-CoV-2 environmental contamination from hospitalised COVID-19 patients receiving aerosol generating procedures
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21259945
20.
Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20153320